News

Xanodyne has received approval from the FDA for Zipsor (diclofenac potassium) Liquid Filled Capsules, to treat mild-to-moderate acute pain in adults. The recommended daily dose of diclofenac potassium

NxStage’ subsidiary, Medisystems has signed a five year distribution agreement with Gambro. Under the agreement, Medisystems will supply blood tubing sets, including the ReadySet and the Streamline to

Canada-based Neuromed has sold the US rights of its investigational drug candidate, Exalgo (hydromorphone HCl), an extended-release tablets, to Covidien’s subsidiary, Mallinckrodt. Neuromed has received a one-time upfront

Access has signed evaluation agreements with two biopharmaceutical companies, for its Cobalamin oral drug delivery technology. Cobalamin technology utilizes the body’s natural vitamin B12 oral uptake mechanism to

Epeius’ Rexin-G has been granted FDA’ fast track designation, for use as a second-line treatment for advanced or metastatic pancreatic cancer. The designation is granted following a critical

GlaxoSmithKline and Genmab have announced that the FDA has informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months.

Bayer has been commissioned by Berzelius, to build a sulfuric acid plant operating on the BAYQIK process. The plant has now been successfully brought on stream after just

The Healthcare & Science business of Thomson Reuters has announced that it is joining Research4Life to provide the developing world with access to critical scientific research. Special editions

Schering-Plough has triggered its pre-existing option to extend the current collaboration with MorphoSys for another year. Schering-Plough will have continued access to MorphoSys’s proprietary antibody HuCAL GOLD, and